Finance

Lists
1AE:ETR
argenx SE
731,40 €
+0,14%
(+1,00) 1D
12-окт., 17:16:05 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1AE...
Open
737,80 €
High
745,00 €
Low
731,40 €
Mkt. cap
46,08 млд
Avg. vol.
78,00
Volume
17,00
P/E ratio
31,12
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 миң
Open
737,80 €
High
745,00 €
Low
731,40 €
Mkt. cap
46,08 млд
Avg. vol.
78,00
Volume
17,00
P/E ratio
31,12
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 миң
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
9 саат мурун
argenx stock pre-market at EUR 734.10
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE
CEO-
Employees1,86 миң
Founded2008-ж., 25-апр.
Headquarters-
Sector-
Websiteargenx.com
Next call 10 күндөн кийин
22-окт., бейш., 09:00
Fiscal period
Q3 2026
- / -9,78 USD
Revenue / Est. (USD)
- / 1,64 млд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,15 млд
1,31 млд
1,31 млд
1,54 млд
Cost of goods sold
465,08 млн
521,40 млн
564,00 млн
631,00 млн
Cost of revenue
465,08 млн
521,40 млн
564,00 млн
631,00 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,29 млн
429,62 млн
355,00 млн
417,00 млн
Operating expense
336,29 млн
429,62 млн
355,00 млн
417,00 млн
Total operating expenses
801,37 млн
951,02 млн
919,00 млн
1,05 млд
Operating income
349,97 млн
359,56 млн
394,00 млн
493,00 млн
Other non operating income
-
-907,00 миң
-
-1,00 млн
EBT including unusual items
386,05 млн
403,29 млн
426,00 млн
531,00 млн
EBT excluding unusual items
386,05 млн
391,71 млн
426,00 млн
531,00 млн
Income tax expense
41,80 млн
-129,66 млн
60,00 млн
59,00 млн
Effective tax rate
10,83%
-32,15%
14,08%
11,11%
Other operating expenses
-
-
-
-
Net income
344,26 млн
532,95 млн
366,00 млн
472,00 млн
Net profit margin
29,90%
40,67%
27,88%
30,63%
Earnings per share
5,18
8,02
5,52
7,32
Interest and investment income
42,70 млн
44,95 млн
44,00 млн
48,00 млн
Interest expense
-993,00 миң
-
-1,00 млн
-1,00 млн
Net interest expenses
41,71 млн
44,95 млн
43,00 млн
47,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
350,35 млн
361,38 млн
395,82 млн
501,50 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору